Global Precision Medicine Market Forecast 2019-2029
The global precision medicine market is expected to grow at an estimated CAGR of 10.5% from 2018 to 2029. In the precision medicine market, the Diagnostic Tool companies’ segment is dominating the global market and accounted for $23.36 billion in 2018 due to the development of large number of diagnostic and genetic tests.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 212-page report you will receive 98 tables and 63 figures– all unavailable elsewhere.
The 212-page report provides clear detailed insight into the global precision medicine market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
- Global Precision Medicine Market forecasts from 2019-2029
- Along with revenue prediction for the overall market for the global precision medicine market, our investigation shows forecasts to 2029 for the market segmented by technology:
- Companion Diagnostics
- Biomarker-based Test
- Targeted Therapeutics
- Pharmacogenomics
- Molecular Diagnostics
- This report breaks down the precision medicine market forecast to 2029 by end-users:
- Pharmaceuticals & Biotechnology Companies
- Diagnostic Companies
- Healthcare IT/Big Data Companies
- Clinical Laboratories
- This report also breaks down the precision medicine market forecast to 2029 by therapeutic application:
- Cancer
- Cardiovascular Diseases
- Central Nervous System
- Infectious Diseases
- Immunology
- Others
- This study provides precision medicine market forecasts to 2029 for these regional markets:
- North America: US & Canada
- Europe: Germany, UK, France, Italy, Spain, Rest of Europe
- Asia-Pacific: China, japan, India, Australia, South Korea, Rest of Asia-Pacific
- Middle East & Africa: South Africa, Saudi Arabia, Rest of Middle East & Africa
- Latin America: Brazil, Mexico, Rest of Latin America
- This report profiles selected leading companies that are the main players in the global precision medicine market:
- Abbott
- Danaher Corporation
- GE Healthcare
- GlaxoSmithKline
- Illumina, Inc.
- Johnson & Johnson
- Laboratory Corporation of America Holdings
- Novartis
- Pfizer
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Our study discusses the drivers, restraints as well as the opportunities in the global precision medicine market.
- This study also analyzed the global precision medicine market with Porter’s Five Forces Analysis as well as Value Chain Analysis
- This report discusses selected market developments in the precision medicine market: partnership, collaboration, join venture, acquisitions, product launch, product development, expansions, patents, approvals.
Visiongain’s study is intended for anyone requiring commercial analyses for the global precision medicine market. You find data, trends and predictions.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.
- 1. Report Overview
- 1.1 Global Precision Medicine Market Overview
- 1.1.1 Precision Medicine Market – Segmentation by Technology
- 1.1.2 Precision Medicine Market – Segmentation by End Users
- 1.1.3 Precision Medicine Market – Segmentation by Therapeutic Application
- 1.1.4 Precision Medicine Market – Segmentation by Geography
- 1.2 Why You Should Read This Report
- 1.3 How This Report Delivers
- 1.4 Key Questions Answered by This Analytical Report Include
- 1.5 Who is This Report For?
- 1.6 Methodology
- 1.6.1 Primary Research
- 1.6.2 Secondary Research
- 1.6.3 Market Evaluation & Forecasting Methodology
- 1.7 Frequently Asked Questions (FAQ)
- 1.8 Associated Visiongain Reports
- 1.9 About Visiongain
- 2. Introduction to Precision Medicine
- 2.1 Evolution and Brief History of Precision Medicine
- 2.2 Key Benefits of Precision Medicine
- 2.3 Precision Medicine: Key Areas of Application
- 2.4 Precision Medicine: Key Elements
- 2.5 Precision Medicine: Different Type of Data Used by Big Data Companies
- 2.6 Precision Medicine: Area of Interest
- 3. Global Precision Medicine Market 2019-2029
- 3.1 Global Precision Medicine Market by End-Users, 2019-2029
- 3.2 Global Precision Medicine Market by Technology, 2019-2029
- 3.3 Global Precision Medicine Market by Therapeutic Application, 2019-2029
- 3.4 Global Precision Medicine Market by Geography, 2019-2029
- 4. Market Dynamics
- 4.1 Global Precision Medicine Market Drivers
- 4.1.1 Upcoming Technologies in Healthcare
- 4.1.2 Collaboration of Big Data Companies with Pharma & Biotech Companies
- 4.1.3 Greater Involvement in Personal Healthcare
- 4.1.4 A Rise in Genetic Diseases
- 4.1.5 Growing Demand for Targeted Therapies
- 4.2 Global Precision Medicine Market Restraints
- 4.2.1 Limitations in Application due to Lack of Research and Evidences
- 4.2.2 Stringent Regulatory Framework and Reimbursement Policies
- 4.2.3 Stringent Regulations and Standards
- 4.2.4 Higher Cost of Diagnostics
- 4.2.5 Risk to Personal Data
- 4.2.6 Risk of failure of Software or Hardware
- 4.2.7 Lack of Knowledge and Awareness
- 4.3 Global Precision Medicine Market Opportunities
- 4.3.1 Increasing Awareness in Developing Economies
- 4.3.2 Reduction in the cost of Genome Sequencing
- 4.4 Regulatory Bodies
- 4.4.1 Food and Drug Administration (FDA)
- 4.4.2 Medicines and Healthcare Products Regulatory Agency (MHRA)
- 4.4.3 Therapeutic Goods Administration (TGA)-Australia
- 4.4.4 Conformité Européenne (CE)
- 4.5 Consortiums
- 4.6 Alliances/Associations
- 5. Global Precision Medicine Market Forecast 2019-2029 - Segmented by End-Users
- 5.1 Introduction
- 5.1.1 Global Precision Medicine Market Forecast 2019-2029: Segmented by End-Users
- 5.2 Global Pharmaceuticals and Biotechnology Companies Submarket Forecast 2019-2029
- 5.2.1 Key Market Trends, Developments and Participants
- 5.2.1.1 Market Trends
- 5.2.1.2 Market Developments
- 5.2.1.3 Key Participants
- 5.3 Global Diagnostic Tools Companies Submarket Forecast 2019-2029
- 5.3.1 Key Market Trends, Developments and Participants
- 5.3.1.1 Market Trends
- 5.3.1.2 Market Developments
- 5.3.1.3 Key Participants
- 5.4 Global Healthcare IT Specialists/ Big Data Companies Submarket Forecast 2019-2029
- 5.4.1 Key Market Trends, Developments and Participants
- 5.4.1.1 Market Trends
- 5.4.1.2 Market Developments
- 5.4.1.3 Key Participants
- 5.5 Global Clinical Laboratories Submarket Forecast 2019-2029
- 5.5.1 Key Market Trends, Developments and Participants
- 5.5.1.1 Regulatory bodies and compliances
- 5.5.1.2 Market Trends
- 5.5.1.3 Key Participants
- 6. Global Precision Medicine Market Forecast 2019-2029 - Segmented by Technology
- 6.1 Introduction
- 6.1.1 Global Precision Medicine Market Forecast 2019-2029: Segmented by Technology
- 6.2 Global Companion Diagnostics Submarket Forecast 2019-2029
- 6.3 Global Biomarkers Submarket Forecast 2019-2029
- 6.3.1 Role of Biobanking in Biomarker
- 6.3.2 Key Participants
- 6.4 Global Biobanking in Targeted Therapeutics Submarket Forecast 2019-2029
- 6.4.1 Key Participants
- 6.5 Global Pharmacogenomics Submarket Forecast 2019-2029
- 6.5.1 Key Market Trends, Developments and Participants
- 6.5.1.1 Market Trends
- 6.5.1.2 Market Developments
- 6.5.1.3 Key Participants
- 6.6 Global Molecular Diagnostics Submarket Forecast 2019-2029
- 7. Global Precision Medicine Market Forecast 2019-2029: Segmented by Therapeutic Application
- 7.1 Introduction
- 7.1.1 Global Precision Medicine Market Forecast 2019-2029: Segmented by Therapeutic Application
- 7.2 Global Cancer Submarket Forecast 2019-2029
- 7.2.1 Types of Cancer
- 7.2.2 Key Market Trends, Developments & Participants
- 7.2.2.1 Market Trends
- 7.2.2.2 Market Developments
- 7.2.2.3 Key Participants
- 7.3 Global Cardiovascular Disease (CVD) Submarket Forecast 2019-2029
- 7.3.1 Drugs & Tests
- 7.3.2 Market Trends & Market Developments
- 7.3.2.1 Market Trends
- 7.3.2.2 Market Developments
- 7.3.2.3 Key Participants
- 7.4 Global Central Nervous System (CNS) Market Forecast 2019-2029
- 7.4.1 Neurological
- 7.4.1.1 Neurological Drugs & Tests
- 7.4.2 Psychiatric Disorders
- 7.4.2.1 Psychiatric Disorder Drugs & Tests
- 7.4.3 Market Trends & Market Developments
- 7.4.3.1 Market Trends
- 7.4.3.2 Key Participants
- 7.5 Global Infectious Diseases Submarket Forecast 2019-2029
- 7.5.1 Infectious Diseases Drugs & Tests
- 7.5.2 Market Developments & participants
- 7.5.2.1 Key Developments
- 7.5.2.2 Key Participants
- 7.6 Global Immunology Market Forecast 2019-2029
- 7.6.1 Market Trends
- 7.6.1.1 Market Trends
- 7.7 Global Other Therapeutic Application Submarket Forecast 2019-2029
- 7.7.1 Market Trends, Developments & Participants
- 7.7.1.1 Market Trends
- 7.7.1.2 Key Developments
- 7.7.1.3 Key Participants
- 8 Global Precision Medicine Market Forecast 2019-2029 – Segmented by Geography
- 8.1 Introduction
- 8.2 North America Precision Medicine Market Forecast 2019-2029
- 8.2.1 U.S.
- 8.2.1.2 Canada
- 8.2.1.3 Key Market Trends, Developments and Participants
- 8.2.1.3.1 Regulations and Compliances
- 8.2.1.3.2 Market Trends
- 8.2.1.3.3 Market Developments
- 8.2.1.4 Key Participants
- 8.3 Europe Precision Medicine Market Forecast 2019-2029
- 8.3.1 Key Market Trends, Developments and Participants
- 8.3.1.1 Regulations and Compliances
- 8.3.1.2 Market Developments
- 8.3.1.3 Key Participants
- 8.4 Asia-Pacific (APAC) Precision Medicine Market Forecast 2019-2029
- 8.4.1 Key Market Trends, Developments and Participants
- 8.4.1.1 Market Developments
- 8.4.1.2 Key Participants
- 8.5 Middle East & Africa Precision Medicine Market Forecast 2019-2029
- 8.5.1 Key Market Developments and Participants
- 8.5.1.1 Market Developments
- 8.5.1.2 Key Participants
- 8.6 Latin America Precision Medicine Market Forecast 2019-2029
- 8.6.1 Key Market Developments and Participants
- 8.6.1.1 Market Developments
- 8.6.1.2 Key Participants
- 9. Market Analysis
- 9.1 Porter’s Five Forces Analysis
- 9.1.1 Bargaining Power of Suppliers
- 9.1.2 Bargaining Power of Buyer
- 9.1.3 Industry Rivalry
- 9.1.4 Threat of New Entrants
- 9.1.5 Threat of Substitutes
- 9.2 Value Chain Analysis
- 9.2.1 Device Manufacturer & Drug Producers
- 9.2.2 Healthcare Providers
- 9.2.3 Healthcare IT Or Big Data Companies
- 9.2.4 Regulators
- 9.2.5 Third Party Payers
- 9.2.6 Patients
- 10. Company Profiles
- 10.1 Abbott Laboratories: Overview
- 10.1.1 Abbott Laboratories: Products & Service
- 10.1.2 Abbott Laboratories: Key Developments
- 10.1.3 Abbott Laboratories: Future Outlook and Growth Strategy
- 10.2 GE Healthcare: Overview
- 10.2.1 GE Healthcare: Products & Service
- 10.2.2 GE Healthcare: Key Developments
- 10.2.3 GE Healthcare: Future Outlook and Growth Strategy
- 10.3 GlaxoSmithKline plc: Overview
- 10.3.1 GlaxoSmithKline plc: Products & Service
- 10.3.2 GlaxoSmithKline plc: Future Outlook and Growth Strategy
- 10.4 Johnson & Johnson: Overview
- 10.4.1 Johnson & Johnson: Products & Service
- 10.4.2 Johnson & Johnson: Key Developments
- 10.4.3 Johnson & Johnson: Future Outlook and Growth Strategy
- 10.5 Pfizer Inc.: Overview
- 10.5.1 Pfizer Inc.: Products & Service
- 10.5.2 Pfizer Inc.: Key Developments
- 10.5.3 Pfizer Inc.: Future Outlook and Growth Strategy
- 10.6 Laboratory Corporation of America Holdings Overview
- 10.6.1 Laboratory Corporation of America Holdings: Products & Service
- 10.6.2 Laboratory Corporation of America Holdings: Key Developments
- 10.7 Danaher Corporation: Overview
- 10.7.1 Danaher Corporation: Products & Service
- 10.7.2 Danaher Corporation: Key Developments
- 10.8 QAGEN: Overview
- 10.8.1 QIAGEN: Products & Service
- 10.9 Thermo Fisher Scientific, Inc.: Overview
- 10.9.1 Thermo Fisher Scientific: Products & Service & Recent Developments
- 10.10 Illumina, Inc.: Overview
- 10.10.1 Illumina, Inc.: Products & Service & Recent Developments
- 10.11 Novartis AG: Overview
- 10.11.1 Novartis AG: Recent Developments
- 11. Competitive Landscape
- 11.1 Introduction
- 11.1.1 Partnerships, Collaborations and Joint Ventures
- 11.1.2 Product Launch/Development
- 11.1.3 Acquisitions
- 11.1.4 Expansion
- 11.1.5 Patents, Approvals and Certifications
- 11.1.6 Others
- Appendices
- Associated Visiongain Reports
- Visiongain Report Sales Order Form
- About Visiongain
- Visiongain Report Evaluation Form
- List of Tables
- Table 2.1 Key Benefits of Precision Medicine
- Table 2.2 Key Elements of Precision Medicine
- Table 4.1 Key Benefits of Precision Medicine for Patients
- Table 4.2 Key Laws & Regulatory Bodies in the Precision Medicine Industry
- Table 4.3 Key Consortiums in the Precision Medicine Industry
- Table 4.4 Key Alliances/Associations in the Precision Medicine Industry
- Table 5.1 Global Precision Medicine Market Forecast by End-Users: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 5.2 Global Pharma & Biotech Companies End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 5.3 Key Developments in Pharma & Biotech Companies
- Table 5.4 Global Diagnostic Tool Companies End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 5.5 Key Developments in Diagnostic Companies
- Table 5.6 Global Healthcare ITs/Big Data End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 5.7 Key Developments in Healthcare IT/Big Data Companies
- Table 5.8 Global Clinical Laboratories Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 6.1 Global Precision Medicine Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 6.2 Global Companion Diagnostics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 6.3 List of Approved Companion Diagnostic Devices
- Table 6.4 Global Biomarkers Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 6.5 List of Biobanks
- Table 6.6 Examples of Biobanking Initiatives Across Selected OECD Countries
- Table 6.7 Global Biobanking in Targeted Therapeutics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 6.8 Global Pharmacogenomics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 6.9 Market Developments
- Table 6.10 Global Molecular Diagnostics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 6.11 Some Examples of Human Genetic Tests That Have Been Approved by the FDA
- Table 6.12 Some Examples of Microbial Tests That Have Been Approved by the FDA
- Table 7.1 Global Precision Medicine Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 7.2 Global Cancer Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 7.3 Precision Medicine Drugs and Relevant Genes: Oncology
- Table 7.4 Precision Medicine Genetic Tests with Respect to Oncology
- Table 7.5 Key Developments
- Table 7.6 Global Cardiovascular Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
- Table 7.7 Precision Medicine Drugs and Relevant Genes: Cardiovascular
- Table 7.8 Precision Medicine Genetic Tests with Respect to Cardiovascular
- Table 7.9 Key Developments
- Table 7.10 Global CNS Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
- Table 7.11 Precision Medicine Drugs and Relevant Genes: Neurology
- Table 7.12 Precision Medicine Drugs and Relevant Genes: Psychiatric Disorders
- Table 7.13 Precision Medicine Genetic Tests with Respect to Psychiatric Disorders
- Table 7.14 Psychiatric Disorders: Key Developments
- Table 7.15 Global Infectious Disease Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
- Table 7.16 Precision Medicine Drugs and Relevant Genes: Infectious Diseases
- Table 7.17 Key Developments
- Table 7.18 Global Immunology Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
- Table 7.19 Global Other Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
- Table 7.20 Precision Medicine Drugs and Relevant Genes: Other Diseases
- Table 7.21 Precision Medicine Genetic Tests with Respect to Other Diseases
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook